HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Natural Brands Work To Deter Lawsuits, Some More Successfully Than Others

This article was originally published in The Rose Sheet

Executive Summary

Johnson & Johnson and Hain Celestial brands are among those whose natural personal-care claims have resulted in costly lawsuits in the U.S., while other leading natural players have been more successful in avoiding litigation. Abstaining from absolute natural assertions, defining the parameters of natural claims in the context of marketing materials and certifying offerings to private natural standards are tactics that may help, though ultimately there are no guarantees in this largely unregulated landscape at present.

You may also be interested in...

CBD Suits Challenge ‘THC-Free’ Claims After Users Fail Drug Tests; Plaintiffs Bar May Just Be Warming Up

Attorneys are warning CBD product marketers to be on guard for litigation challenging the authenticity of their claims, the safety of their products and other aspects of their businesses. So far, suits of this nature have been limited in the US, but the few known cases could be harbingers of a larger wave to come.

J&J Agrees To $6.75M Aveeno Active Naturals Class Settlement

The firm failed in motions to dismiss plaintiff claims and block class certification in a suit alleging that Aveeno Active Naturals products are falsely advertised because they contain synthetic ingredients. Meanwhile, class certification was granted recently in a separate case concerning Aveeno Baby "natural" claims, which could portend another settlement to come.

FTC Action On 'All Natural' Claims Likely To 'Embolden' Plaintiffs

Attorneys agree that FTC's announced settlements with personal-care companies for misleading "all-natural" claims likely will not be helpful to class-action defendants making primary-jurisdiction arguments and could actually spur more litigation, similar to trends following FDA warning letters.

Related Content

Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts